Hey Mary Mary quite contrary. This boring stock went up more than 11% on Friday. I hope that there iare many many similar boring days ahead. In this way you would be able to stop advertising "ultimate stock alerts" on this message Board.
It appears that you may be correct. Since the relatively good news originally had the stock going up and then selling came in to reverse the stock to the down side several times. I wrotye a letter to management indicating my concern and naturally there was no response. I will wait until May 5th when by which date they are supposed to submit something to the Nasdaq indicating how they are going to get back to the capitalization amount. It is quite easy to do and the good news deserves that the stock go up. The Company itself indicated that they wanted to be listed because it would be easier to get further funds for investment purposes. That is the reason they used to split the stock originally. I intend to write this to the CEO of the Company before I do other things which I believe are required to protect the interest of the small shareholders.`I hope that what you are indicating is wrong. Management owes a fiduciary relationship and legal obligation to all shareholders. In summary, the value of this stock of CSB in relationship to the positive financial information that they are reporting seem to be going in opposite directions. The better the info, the lower the value of the stock. To me this is unacceptable and if management is involved ion keeping the value of this stock low, it is called insider stock manipuilation and, I believe, is illegal.
On a post reverse split basis, CSBR was once valued at about $26.00 per share ($2.15) pre- split basis. This was before any revenues. As revenues increased substantially the value of this stock has gone down. No value whatsoever has been given to the tumorgraft library that has been and continues to be developed. Management has been completely derelict in creating value for this Company considering its continued financial statement increases in revenues and decreases in losses. Since no one is abandoning ship as far as management is concerned and since financially everything apparently is getting much better, the only conclusion that one can draw is that this Company is way undervalued. I continue to believe that someday this Company will be sold. It remains to be seen at what multiple times revenues it will be sold at. It is always difficult to determine the value of a growing biotechnology Company. Hiowever, one of the criteria that should be used, as I researched this matter, seems to be a valuation iof 8 times assets. I believe that it should be valued at 5 times revenues. Either way, I believe that this stock is 50% undervalued at this point and is a gereat buy..
Watch out for the trap. There is no resonable explanation for this stock to drop as much as it did. This stock will move smartly upward from its low at the opening. It is a trap to get your sheares away from you and then move the stock significantly higher. Do not fall the sharks who are out to" stea"l your shares.